Three doses of COVID-19 vaccine neutralise Omicron variant Pfizer

38



Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralise the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralisation titers, the vaccine manufacturing companies have said. The companies made this known in a joint statement on Wednesday titled, Pfizer and BioNTech provide update on Omicron variant. Chairman and Chief Read More



Source: Punch Newspaper

Get the Latest Business Tenders and Contracts Information